TABLE 3.
Surgical and Adjuvant Treatments of the Cohort
| Characteristic | Category | N (%) |
|---|---|---|
| Time to surgery (mo) | Median (IQR) | 1.4 (0.5–4.4) |
| WHO grade | 1 | 195 (82.6) |
| 2 | 40 (16.9) | |
| 3 | 1 (0.4) | |
| Ki-67 index | Median (IQR) | 7.0 (4.3–11.3) |
| Residual tumor volume (cm3) | Median (IQR) | 2.0 (0.8–5.2) |
| Percentage of original tumor resected (%) | Median (IQR) | 92.1 (77.5–97.5) |
| Percentage of original tumor remaining (%) | Median (IQR) | 7.9 (2.5–22.5) |
| Additional treatments | No treatment | 156 (66.1) |
| FRT | 68 (28.8) | |
| SRS | 12 (5.1) | |
| Time to FRT (months) | Median (IQR) | 10.9 (4.0–44.9) |
| Adjuvanta FRT? | Yes | 31 (13.1) |
| No | 205 (86.9) | |
| Adjuvant FRT dose (Gy) | 54 | 29 (80.6) |
| 60 | 7 (19.4) | |
| SRS | Yes | 12 (5.1) |
| No | 224 (94.9) | |
| SRS dose (Gy) | 12.5 | 3 (25.0) |
| 15.0 | 9 (75.0) | |
| Time to SRS (mo) | Median (IQR) | 41.3 (15.0–55.2) |
a
Adjuvant FRT defined as patient receiving FRT within 6 months of the original surgery.